Nothing publicly stated. Hopefully we'll get details in the quarterly due by the end of the month.
At the height they were running at close to 90% capacity, I am not sure they'd be prepared to run so high in the contract space at present with them hoping to increase output of their own products to Canada, Australia and the European Union, etc.
Where before their forward cashburn figures was suggesting they'd need more funds towards the end of 2022, this burst of demand could either push that back 6 to 12 months, or possibly even suffice to carry them through to positive cashflow post this current demand period with FebriDx, CoviDx, etc growth if approvals comes through sooner than later.
Ann: Over 100 Pharmacies in Liverpool UK Launch FebriDx Service, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $19.14M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.4¢ | $102.3K | 2.948M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 621826 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 315000 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| LDX (ASX) Chart |